Anticoagulants - Administration & dosage
Research News and Information

Sunday, November 22, 2009

Laser treatment of benign prostatic hyperplasia in patients on oral anticoagulant therapy: a review.

20 Dec 2009 We assessed the therapeutic efficacy and safety of laser prostatectomy (LP) for treating benign prostatic hyperplasia (BPH) in patients on oral anticoagulation. We systematically reviewed previous reports, using the Pubmed database and ... Read more...

Budd-Chiari syndrome as a vascular complication of amebic liver abscess.

30 Oct 2009 Amebiasis remains a major public health issue in most of the world. Amebic liver abscess is the most common extraintestinal manifestation. A complication such as venous obstruction associated with amebiais is rare. We report a thrombosis in hepatic ... Read more...

Comparison of prolonged bivalirudin infusion versus intraprocedural in preventing myocardial damage after percutaneous coronary intervention in patients with angina pectoris.

13 Oct 2009 Modern antithrombotic strategies for patients undergoing percutaneous coronary interventions (PCIs) must take into account the risk of ischemic and hemorrhagic complications. Bivalirudin decreases the risk of hemorrhagic complications after PCI; ... Read more...

Latest indexed articles for 'Anticoagulants - Administration & dosage'

These are the very latest articles for this heading:

• Laser treatment of benign prostatic hyperplasia in patients on oral anticoagulant therapy: a review. 20 Dec 2009
• Budd-Chiari syndrome as a vascular complication of amebic liver abscess. 30 Oct 2009
• Comparison of prolonged bivalirudin infusion versus intraprocedural in preventing myocardial damage after percutaneous coronary intervention in patients with angina pectoris. 13 Oct 2009
• Bleeding increases the risk of ischemic events in patients with peripheral arterial disease. 3 Oct 2009
• Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. 27 Sep 2009
• Incidence and causes of heparin-induced skin lesions. 26 Sep 2009
• Computerized decision support for the cardiovascular clinician: applications for venous thromboembolism prevention and beyond. 20 Sep 2009
• Fondaparinux for prevention of venous thromboembolism in high-risk trauma patients: a pilot study. 9 Sep 2009
• New antithrombotic drugs: potential for use in oncology. 6 Sep 2009
• Improved oral anticoagulation after a dietary vitamin k-guided strategy: a randomized controlled trial. 6 Sep 2009
• Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 years. 6 Sep 2009
• [Anesthetic management for a patient with heparin-induced thrombocytopenia (HIT) undergoing off-pump coronary bypass surgery using argatroban, a direct thrombin inhibitor] 30 Aug 2009
• Low-molecular-weight heparin for thromboprophylaxis. 30 Aug 2009
• Malabsorption-associated warfarin resistance. 30 Aug 2009
• Anticoagulation and coagulation management for ECMO. 30 Aug 2009
• What influence do anticoagulants have on oral implant therapy? A systematic review. 30 Aug 2009
• I take a blood thinner daily. Before year's end, I'm scheduled to have a couple of teeth pulled. My dentist wants me to stop my medicine a day or two beforehand so that there won't be too much bleeding, but a friend says her doctor told her not to stop the medication ahead of time. I'm confused. 30 Aug 2009
• A new era for oral anticoagulants: have we finally evolved beyond warfarin? 30 Aug 2009
• Epidural steroid injection resulting in epidural hematoma in a patient despite strict adherence to anticoagulation guidelines. 30 Aug 2009
• "Drip-and-ship," "Stay-and-pray," "Freight-and-wait (and possibly inflate)" or simply opening the window wider?: Decision-making regarding time delays in the treatment of ST elevation MI. 30 Aug 2009

See a longer list of these articles.

Technical information about 'Anticoagulants'

Definition: Agents that prevent blood clotting. Naturally occurring agents in the blood are included only when they are used as drugs.

Registry Number: 0

Descriptor UI: D000925

Alternative terms: Anticoagulants; Anticoagulant Agents; Agents, Anticoagulant; Anticoagulant Drugs; Drugs, Anticoagulant;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.954.502.119;

Technical Notes: not for circulating natural anticoagulants; consider also BLOOD COAGULATION /drug eff & THROMBOSIS /drug ther or related dis with /drug ther; DF: ANTICOAG